FindTrial
Sign In

Botulinum Toxin A (Botox )

DRUG5 trials

Sponsors

Assistance Publique - Hôpitaux de Paris, The Cleveland Clinic, Mansoura University, Shaare Zedek Medical Center, Hacettepe University

Conditions

Delayed Gastric Emptying Following ProcedureEsophageal AchalasiaEsophageal Cancer SurgeryEsophageal DiseasesEsophageal DysmotilityEsophagectomyFecal IncontinenceMyofascial Pain - Dysfunction Syndrome of TMJ

Early Phase 1

Intra-rectal Botulinum Toxin Injection for Intractable Non-retentive Fecal Incontinence in Children - an Open Label Pilot Study
Not yet recruitingNCT06785844
Shaare Zedek Medical CenterFecal Incontinence
Start: 2025-02-01End: 2030-09-30Target: 14Updated: 2025-01-24

Phase 2

Efficacy and Safety of Botulinum Toxin A for the Treatment of Refractory Overactive Bladder.
CompletedNCT00231491
Assistance Publique - Hôpitaux de ParisOveractive Bladder
Start: 2005-11-30End: 2010-04-30Updated: 2011-02-17
Effectiveness of Methods for Pyloric Drainage in esophagecTomY: Botox vs. Pyloromyotomy
RecruitingNCT06721520
The Cleveland ClinicDelayed Gastric Emptying Following Procedure, Esophageal Achalasia, Esophageal Cancer Surgery +4
Start: 2024-12-03End: 2028-05-31Target: 170Updated: 2026-02-25

Phase 4

Biofeedback Therapy Versus Botox Injection in Treatment of Dyssynergic Defecation.
CompletedNCT06724250
Mansoura UniversityObstructed Defaecation Syndrome
Start: 2023-08-01End: 2024-09-30Updated: 2024-12-09

Unknown Phase

Efficiency of Botulinum Toxin type-a in the Management of the Myofascial Pain
CompletedNCT06840730
Hacettepe UniversityMyofascial Pain - Dysfunction Syndrome of TMJ
Start: 2024-06-03End: 2025-04-13Updated: 2026-02-18

Related Papers

Efficacy and safety of low doses of onabotulinumtoxinA for the treatment of refractory idiopathic overactive bladder: a multicentre, double-blind, randomised, placebo-controlled dose-ranging study.
2011-10-25105 citations